CA2233173A1 - Dopamine and serotonin transporter ligands and imaging agents - Google Patents

Dopamine and serotonin transporter ligands and imaging agents

Info

Publication number
CA2233173A1
CA2233173A1 CA002233173A CA2233173A CA2233173A1 CA 2233173 A1 CA2233173 A1 CA 2233173A1 CA 002233173 A CA002233173 A CA 002233173A CA 2233173 A CA2233173 A CA 2233173A CA 2233173 A1 CA2233173 A1 CA 2233173A1
Authority
CA
Canada
Prior art keywords
imaging agents
dopamine
compounds
serotonin transporter
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002233173A
Other languages
French (fr)
Other versions
CA2233173C (en
Inventor
Hank F. Kung
Sanath Meegalla
Mei-Ping Kung
Karl Plossl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/649,782 external-priority patent/US6241963B1/en
Application filed by Individual filed Critical Individual
Publication of CA2233173A1 publication Critical patent/CA2233173A1/en
Application granted granted Critical
Publication of CA2233173C publication Critical patent/CA2233173C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

This invention presents a series of novel tropane-based derivatives complexed with either technetium or rhenium having the formula (See formula I) with X, Z, N, and Q being specifically defined herein.
These compounds are specific for central nervous system receptors, in particular, dopamine or serotonin receptors. The compounds of the invention have utility, inter alia, as imaging agents for CNS receptors. Methods of using these novel compounds as imaging agents are presented, as are intermediates and methods for making these novel compounds.
CA002233173A 1995-10-19 1996-10-21 Dopamine and serotonin transporter ligands and imaging agents Expired - Fee Related CA2233173C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54532795A 1995-10-19 1995-10-19
US08/545,327 1995-10-19
US08/649,782 US6241963B1 (en) 1995-10-19 1996-05-17 Dopamine and serotonin transporter ligands and imaging agents
US08/649,782 1996-05-17
PCT/US1996/016908 WO1997014445A1 (en) 1995-10-19 1996-10-21 Dopamine and serotonin transporter ligands and imaging agents

Publications (2)

Publication Number Publication Date
CA2233173A1 true CA2233173A1 (en) 1997-04-24
CA2233173C CA2233173C (en) 2006-04-04

Family

ID=36143343

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002233173A Expired - Fee Related CA2233173C (en) 1995-10-19 1996-10-21 Dopamine and serotonin transporter ligands and imaging agents

Country Status (1)

Country Link
CA (1) CA2233173C (en)

Also Published As

Publication number Publication date
CA2233173C (en) 2006-04-04

Similar Documents

Publication Publication Date Title
PT929319E (en) DOPAMINE AND SEROTONIN TRANSPORTER LIGANDS AND IMAGE AGENTS
NZ330023A (en) Fused pyrrolecarboxanilides and their use as a GABA brain receptor ligands
CA2128955A1 (en) Tricyclic benzazepine vasopressin antagonists
GB2317615B (en) Antifungal agent compound therefor process for producing the same
CA2103861A1 (en) Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
BR1100273A (en) Compound
AU3548993A (en) Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
GB2243150B (en) Method for synthesizing diamond by combustion
YU1302A (en) Aminothiazole derivatives and their use as crf receptor ligands
AU4312396A (en) Five-membered heteroaromatic compounds as dopamine receptor subtype ligands
HUP9900968A3 (en) Herbicidal substituted 3-aryl-pyrazoles, compositions containing them, method for their use and process for preparing the compounds
IL113780A0 (en) Glucopyranoside benzothiophenes
HUT69738A (en) Substituted pyridylsalicylaldehyde-and salicyklicacid derivatives, process for their preparation und their use as herbicide
CA2233173A1 (en) Dopamine and serotonin transporter ligands and imaging agents
ZA961748B (en) Novel process for preparing 2,3-dihydro-benzofuranol derivatives
FI960332A (en) Process for preparing substituted 4,6-diamino-5-cyano-pyrimidines
UA35556C2 (en) process for the preparation of hydrocortisone AND INTERMEDIATE compounds in the synthesis of hydrocortisone
ZA912278B (en) Compounds affecting serotonin receptors
AU4420296A (en) Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
EP0755916A3 (en) Process for the preparation of amine compound
DE69611148T2 (en) Pyrrolo (4,3,2-de) quinoline derivative
DE69711506T2 (en) Methylsulfomycin 1, process for its preparation and use
HU9500962D0 (en) Process for the preparation of substituted, nitrogen containing heterocyclic compounds
CA2367410A1 (en) Novel process for the preparation of 1-phenyl-2-(2-piridyl)ethanamine
FI946172A0 (en) A novel radiolabeled compound, a mixture containing the compound and a process for their preparation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed